This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (adalimumab) 40 mg/0.4 mL pens, a medication used to treat various autoimmune conditions. The contract has a firm fixed price of $1,510.60 and a completion date of April 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,794.58, is for the supply of Humira (adalimumab) 40 mg/0.4 mL pens, a medication used to treat various autoimmune diseases. The contract is a firm-fixed-price delivery order, with a performance period ending on May 2, 2025. This contract is not designated as a set-aside and was...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (adalimumab) 40 mg/0.4 mL prefilled pens, a biologic medication used to treat various autoimmune conditions. The contract has a firm fixed price of $2,265.90 and a performance period ending on April 28, 2025. This contract is not set aside for any specific business...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 40 mg/0.4 mL prefilled pens. The contract has a firm fixed price of $2,188.39 and a performance period through May 1, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Humira (adalimumab) Pen 40 mg/0.4 mL. The contract has a firm fixed price of $16,552.17 and a completion date of September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,506.72, is for the supply of Humira (adalimumab) 40 mg/0.4 mL auto-injector pens, a specialty medication used to treat various inflammatory conditions. The contract has a firm-fixed price and an ultimate completion date of April 25, 2024. This delivery order is...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Humira Pen 40 mg/0.8 mL, a medication used to treat various autoimmune conditions. The contract has a ceiling value of $3,021.20 and is a firm-fixed-price delivery order, with a period of performance running through March 18, 2025. This contract is not set-aside and was...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 40 mg/0.4 mL auto-injector pens. The contract has a firm fixed price of $2,265.90 and a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (adalimumab) auto-injector pens, a biologic medication used to treat various autoimmune diseases. The contract has a firm fixed price of $1,252.47 and a period of performance through April 2025. It is not a set-aside contract, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 40 mg/0.4 mL auto-injector pens. The contract is a firm fixed-price delivery order with a ceiling value of $3,148.60 and a period of performance through April 18, 2025. This contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...